,

NDFS13 Company Presentation: Tangen Biosciences’ Successful Non-Dilutive Funding Journey

John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.


/by
You might also like
NDFS17 InflammatixNDFS17 Video: Inflammatix: Our Road to Success with Non-Dilutive Funding
National Institute of Neurological Disorders and Stroke (NINDS) Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Charles L. CywinNINDS at NDFS 2023, with Dr. Charles L. Cywin
NDFS17 NCINDFS17 Video: NCI Funding & Commercialization Resources for Cancer Tech
Small Business Education and Entrepreneurial Development (SEED), in the Office of the Director, at NIH, presented at the 18th Non-Dilutive Funding Summit, 2023. Director Dr. Matthew McMahonSEED at NDFS 2023, with Director Dr. Matthew McMahon
NDFS17 BARDANDFS17 Video: Non-dilutive funding at BARDA for medical countermeasure R&D
National Institute of Allergy and Infectious Disease Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Natalia KruchininNIAID at NDFS 2023, with Dr. Kruchinin
NDFS17 Abalone BioNDFS17 Video: Abalone Bio’s Pathway to Granting Success
NDFS17 Abalone Bio12th Annual Non-Dilutive Funding Summit Keynote Address